drug: |
methylphenobarbital
|
*| Clinical class | sedative hypnotic, anticonvulsant |
| Action | central nervous system depressant |
| Chemical class | barbiturate |
| CSA schedule | IV |
| DEA number | 2250 |
| Routes of administration | oral |
| Associated with (substance-related)
|
disorders: disorders |
| Availability | prescription |
Also: ephenemal, heptobarbital, mephebarbital, mephobarbital, methobarbital, methylphenobarbitone
U.S. Preparations:
- Mebaral® (Sanofi-Synthelabo) FDA approved indications: a sedative for the relief of anxiety, tension, and apprehension, and as an anticonvulsant for the treatment of grand mal and petit mal epilepsy.
| Dose: | 60 mg. | 200 mg. | |||
| Color: | white | white | |||
| Shape: | cylinder | cylinder | |||
| Type: | tablet | tablet | |||
| Imprint: | "P60" | "P200" | |||
Preparations Outside U.S.:
- Comital
- Mathoine
- Melroin (combination)
- Menta-barb
- Prominal® (Sanofi-Synthelabo) FDA approved for treatment of
: not approved
*Molecule graphic courtesy of Steve Chapman